Drugs Being Discovered That Can Reduce Nerve Damage in Peripheral Neuropathy Sufferers
Research currently underway at the Bar Harbor Lab has uncovered evidence that certain drugs can be effective in reducing the nerve damage and peripheral neuropathy caused by chemotherapy. This nerve damage is present in up to 40 percent of chemotherapy patients.
This study, like many others uses zebrafish, which share 70 percent of their DNA with humans.
Currently, there is no effective treatment for the underlying causes of peripheral neuropathy, which affects 30 to 40 percent of chemotherapy patients. It is hoped this research in the zebrafish model will result in effective treatment for this condition, which can cause disabling difficulty in carrying out everyday activities such as walking, writing, getting dressed and handling small objects.